Sign In
Buy LQDA
$55.69
+0.580 (+1.05%)
At Close: Jun 03, 2026
Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice
01:01pm, Thursday, 28'th May 2026
Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
08:30am, Wednesday, 27'th May 2026
MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and C
4 Low-Beta Stocks for a Steadier Portfolio: LQDA, XOM, VLO & FANG
12:46pm, Wednesday, 20'th May 2026
Middle East tensions are stoking volatility; a low-beta screen spotlights Liquidia, Exxon Mobil, Valero Energy and Diamondback Energy.
Earnings Estimates Moving Higher for Liquidia Corporation (LQDA): Time to Buy?
01:21pm, Thursday, 14'th May 2026
Liquidia Corporation (LQDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:00pm, Wednesday, 13'th May 2026
Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
12:23pm, Wednesday, 13'th May 2026
Liquidia develops therapies for rare cardiopulmonary diseases, leveraging proprietary drug delivery technologies in the U.S. market.
Best Momentum Stocks to Buy for May 13th
11:02am, Wednesday, 13'th May 2026
LQDA, NEXA and NUE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 13th, 2026.
New Strong Buy Stocks for May 13th
06:11am, Wednesday, 13'th May 2026
HCSG, NUE, NEXA, LQDA and NKSH have been added to the Zacks Rank #1 (Strong Buy) List on May 13th, 2026.
These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results
02:06pm, Tuesday, 12'th May 2026
Liquidia Corp (NASDAQ:LQDA) on Monday reported better-than-expected first-quarter financial results.
Liquidia: Yutrepia's Launch Momentum Is Approaching A Ceiling (Rating Downgrade)
05:18am, Tuesday, 12'th May 2026
Liquidia delivered strong Q1 results, with Yutrepia net sales up 44% sequentially and a third consecutive profitable quarter. LQDA now commands a 23% share of the inhaled prostacyclin segment, but fur
Liquidia Corporation (LQDA) Q1 2026 Earnings Call Transcript
11:38am, Monday, 11'th May 2026
Liquidia Corporation (LQDA) Q1 2026 Earnings Call Transcript
Liquidia Q1 Earnings Call Highlights
11:08am, Monday, 11'th May 2026
Liquidia NASDAQ: LQDA reported sharply higher first-quarter 2026 sales and profitability as executives said the launch of YUTREPIA continued to gain traction in pulmonary arterial hypertension and pul
Liquidia Corporation (LQDA) Surpasses Q1 Earnings and Revenue Estimates
08:46am, Monday, 11'th May 2026
Liquidia Corporation (LQDA) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to a loss of $0.45 per share a year ago.
Liquidia Corporation Reports First Quarter 2026 Financial Results
06:30am, Monday, 11'th May 2026
YUTREPIA® (treprostinil) inhalation powder net product sales of approximately $130 million in the first quarter of 2026 More than 4,500 unique patient prescriptions and approximately 3,750 patients t
Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG
12:11pm, Friday, 08'th May 2026
Low beta screen highlights LQDA, CBOE, VLO and FANG as Middle East tensions keep U.S. stocks volatile, and investors favor steadier movers.
